The Study Will Evaluate the Effect of AZD9164 in Patients With Chronic Obstructive Pulmonary Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

AZD9164

Solution for inhalation through nebulization, single dose

DRUG

Tiotropium

Dry powder for inhalation, single dose

DRUG

Placebo

Placebo

Trial Locations (3)

Unknown

Research Site, Gothenburg

Research Site, Luleå

Research Site, Lund

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY